For citations:

Ermolaeva A.D., Ermolaeva T.N., Kokushkin K.A. Pharmacoeconomic Aspects of Using New Generation Drugs Of PCSK-9 Inhibitor and Acting on The Effect of Ribonucleic Acid Interference Classes in The Treatment of Patients With Hypercholesterolemia at High Risk of Cardiovascular Events. Kardiologiia. 2025;65(6):23-33. (In Russ.) https://doi.org/10.18087/cardio.2025.6.n2949